| Name | Title | Contact Details |
|---|
ValenTx was founded with the goal of treating some of the most pervasive health problems of our time: obesity and obesity-related metabolic disorders such as type-2 diabetes and hypertension. Our approach is to create a non-surgical, endoluminal bypass device that builds on the success of established medical interventions, resulting in a highly effective and least-invasive therapy. Current treatments for these diseases include surgery, pharmacology, and medically supervised lifestyle management. The risks, costs, and in some cases poor efficacy of these treatments have hampered their broad adoption by patients, physicians, and payers alike. A truly unmet clinical need exists for a therapy that can deliver the efficacy obtained through surgery, but without the risks and costs associated with surgical intervention. The ValenTx endoluminal bypass therapy mimics the attributes of a Roux-en-Y gastric bypass and is implanted through a non-surgical, endoscopic procedure. This procedure does not require gastric stapling or permanent changes to the patient`s anatomy. The device is removable, replaceable and designed so that the physician could change the therapeutic profile, thereby optimizing the treatment towards the individual patient`s needs. ValenTx has developed a strong intellectual property portfolio, which lies at the foundation of this therapy. The company has successfully conducted a series of clinical studies demonstrating the viability, safety, and efficacy of the therapy.
Kernel is a human intelligence (HI) company. We`re a team of scientists and engineers on a mission to dramatically increase our quality of life and create a thriving humanity. We believe that starts with a renewed focus on human intelligence (HI). Machines of all kinds can help us along the way, but our vision is one in which we humans maintain and expand our authorial power. The advanced intelligence of tomorrow is a collaboration between the natural and the artificial. United, unheard of possibilities abound. We`re building off two decades of breakthrough research, working closely with private partners and scientists to get usable solutions in the hands of people everywhere. We’re starting with potential applications for patients with cognitive disorders.
Baxter provides a broad portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile IV solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics; and pharmacy automation, software and services. The company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.
Linet Americas is a Charlotte, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Drew Scientific is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.